BAXTER AKTIENGESELLSCHAFT
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 30, 2003 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 459 Total Citation Count
- Jun 17, 1992 Earliest Filing
- 22 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6358918 Preparation comprising thiol-group-containing proteinsJul 05, 00Mar 19, 02[A61K, A01N, C07K]
6346513 Proteins with factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing themApr 03, 95Feb 12, 02[A61K, C07K]
6146873 Production of orthomyxoviruses in monkey kidney cells using protein-free mediaOct 15, 97Nov 14, 00[C12N]
6124255 Preparation comprising thiol-group-containing proteinsJan 16, 98Sep 26, 00[A61K, A01N, C07K]
6103244 Methods for generating immune responses employing modified vaccinia of fowlpox virusesMay 22, 96Aug 15, 00[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
6670116 Methods for the detection, quantification and differentiation of infectious versus non-infectious pathogens in a sampleExpiredDec 20, 00Dec 30, 03[C07H, C12Q]
6465170 Method for depleting viral and molecular pathogens in a biological materialExpiredAug 20, 01Oct 15, 02[A61K, A01N, C12N, C02F]
2002/0137,039 5' Nuclease nucleic acid amplification assay having an improved internal controlAbandonedDec 22, 00Sep 26, 02[C12Q, C12P]
2002/0102,548 Methods for the preparation and use of internal standards for nucleic acid amplification assaysAbandonedDec 20, 00Aug 01, 02[C07H, C12Q, C12P]
6414125 Method of chromatographically purifying or fractionating, respectively, von Willebrand factor from a VWF-containing starting materialExpiredOct 21, 99Jul 02, 02[A23J]
6403556 Pharmaceutical preparation containing protein C and a thrombolytically active substanceExpiredJun 17, 92Jun 11, 02[A61K, A01N, C12Q]
6395880 Method for purification of antithrombin III using an anion exchangerExpiredMay 26, 00May 28, 02[A61K, C12N, A23J]
2001/0019,839 Method for production of a C1 esterase inhibitor (C1-INH)-containing compositionAbandonedDec 21, 00Sep 06, 01[A61K, C12N]
6265183 Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteinsExpiredDec 19, 94Jul 24, 01[A61K, C12P, C12N]
6165711 Process for disintegrating nucleic acids and preparing biological products of guaranteed qualityExpiredNov 18, 98Dec 26, 00[C12Q, A01N, C12N]
6077691 High level expression of polypeptide that contains modified preS1 region of hepatitis B virus large antigenExpiredFeb 06, 97Jun 20, 00[A61K, C12P, C12N]
6017891 Stable preparation for the treatment of blood coagulation disordersExpiredSep 05, 97Jan 25, 00[A61K, A01N, A61F]
6013620 Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its useExpiredSep 11, 97Jan 11, 00[A61K, C07K]
6004561 High level expression of polypeptide that contains modified preS1 region of hepatitis B virus large antigenExpiredFeb 07, 97Dec 21, 99[A61K, C12Q, G01N]
6005077 Use of von willebrand factor and pharmaceutical formulationExpiredNov 06, 96Dec 21, 99[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.